Sign in

CIK 0001645113

  • Large accelerated filer

NovoCure Ltd

Sign in to watch
Ticker
NVCR
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Entity type
Operating
Phone
+44 1534756700
Business address
NO. 4 THE FORUM, GRENVILLE STREET, ST. HELIER, Jersey
  1. 4 Open-market sale Director sold 407 shares at $69.61 ($28,331)
  2. 4 Derivatives Options or other derivatives
  3. 4 Grant or award Director acquired 2,427 shares (grant or award)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Grant or award Director acquired 2,427 shares (grant or award)
  7. 4 Derivatives Options or other derivatives
  8. 4 Open-market sale Chief Medical Officer sold 4,205 shares at an average $63.17 ($265,646)
  9. 4 Derivatives Options or other derivatives
  10. 3 Insider Initial Statement of Ownership
  11. 4 Exercise or conversion Chief Financial Officer acquired 5,040 shares (option exercise)
  12. 4 Open-market sale Chief Commercial Officer sold 3,669 shares at $71.19 ($261,196)
  13. 4 Open-market sale Chief Commercial Officer sold 7,775 shares at an average $69.73 ($542,116)
  14. 4 Open-market sale Chief Development Officer sold 744 shares at $70.10 ($52,154)
  15. 4 Open-market sale Chief Human Resources Officer sold 1,037 shares at $70.10 ($72,694)
  16. 4 Open-market sale Chief Operating Officer sold 2,923 shares at $70.10 ($204,902)
  17. 4 Open-market sale Chief Financial Officer sold 759 shares at $70.10 ($53,206)
  18. 4 Open-market sale General Counsel sold 2,339 shares at $70.10 ($163,964)
  19. 4 Open-market sale Executive Chairman sold 2,385 shares at $70.10 ($167,189)
  20. 4 Open-market sale General Counsel sold 3,067 shares at an average $71.87 ($220,414)

Page 12 of 39 · 780 filings